Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 77 for cardiology

Edit search filters
  1. A Study To Evaluate The Safety And Effectiveness Of GORE® CARDIOFORM Septal Occluder To Treat Migraine Headaches

    Scottsdale/Phoenix, AZ

  2. A Study To Evaluate Autologous Bone Marrow Mononuclear Cells Using The CardiAMP™ Cell Therapy In Patients With Post Myocardial Infarction Heart Failure

    Scottsdale/Phoenix, AZ

  3. Study To Investigate CSL112 In Subjects With Acute Coronary Syndrome

    Scottsdale/Phoenix, AZ

  4. Phase 2/3 Study Of Participants With Recurrent Pericarditis Evaluating The Efficacy And Safety Of KPL-387

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Long-Term Safety Extension Study Of Mavacamten In Adults Who Have Completed MAVERICK-HCM Or EXPLORER-HCM

    Jacksonville, FL

  6. A Study to Evaluate the use of Real Time Myocardial Perfusion Echocardiography for Detection of Coronary Allograft Vasculopathy in Heart Transplant Patients

    Rochester, MN

  7. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG

    Scottsdale/Phoenix, AZ

  8. TRITON-CM: A Study To Evaluate Nucresiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Rochester, MN

  9. CorMatrix ECM Tricuspid Valve Replacement

    Rochester, MN

  10. d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

    Rochester, MN

.

Mayo Clinic Footer